Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: all 582 studies
Page 1 of 6. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.
- GLAD-KE GLioma Biomarker and Safety Assessment During Dietary Ketone Elevation Subtitle: A Surgical Biomarker Discovery Study of Ketogenic Therapy in Recurrent GliomaNot yet recruitingNCT07852975Not applicable
- Study of Sarilumab With Immune Checkpoint Inhibitor Rechallenge in Patients With Clinically Significant Immune Related Adverse EventsNot yet recruitingNCT07836101Phase 2
- Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract CancerNot yet recruitingNCT07793253Phase 2
- Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Cancer (UTUC)Not yet recruitingNCT07793240
- Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade GliomasNot yet recruitingNCT07778602Early Phase 1
- Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal CancerNot yet recruitingNCT07580339Phase 2
- PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADTRecruitingNCT07550517Phase 2
- Precision Radiotherapy Enabled by Molecular MRIRecruitingNCT07512154Not applicable
- A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)RecruitingNCT07430202Phase 1
- Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)RecruitingNCT07424222Phase 1
- Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)RecruitingNCT07375992Not applicable
- Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic TumorsRecruitingNCT07360119Not applicable
- Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal CancerRecruitingNCT07281768Phase 2
- Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)RecruitingNCT07209189Phase 2
- Physician- and Patient-based Barriers to NGS TestingRecruitingNCT07209176Not applicable
- Supraphysiologic Testosterone Priming Induces Darolutamide Extended ResponseRecruitingNCT07142551Phase 2
- DK222 Study at HopkinsRecruitingNCT07140315Phase 1
- Pediatric Radiation Therapy RegistryRecruitingNCT07129317
- Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic LeukemiaRecruitingNCT07071155Early Phase 1
- Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal CellRecruitingNCT07062549Phase 1
- NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic CancerRecruitingNCT06941857Phase 2
- The COSMYC Trial (COmbined Suppression of MYC)RecruitingNCT06922318Phase 2
- Proton SBRT for Spinal MetastasisRecruitingNCT06895564Not applicable
- Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate CancerAvailableNCT06836648
- 7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate CancerRecruitingNCT06826924Not applicable
- Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)RecruitingNCT06803745Not applicable
- Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone SarcomaRecruitingNCT06796543Not applicable
- Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic CancerRecruitingNCT06782932Phase 1/2
- Study in Patients With Breast Cancer Leptomeningeal MetastasisRecruitingNCT06638294
- Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian CancerRecruitingNCT06617923Phase 2
- Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate CancerRecruitingNCT06616597Phase 2
- A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered GliomaRecruitingNCT06610682Early Phase 1
- Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)RecruitingNCT06564623Phase 1
- Gut Microbiome, Adverse Effects, and Markers Through MEtabolic ReprogrammingRecruitingNCT06536881Not applicable
- Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood CollectionEnrolling by invitationNCT06508138Phase 1
- Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral ChordomaRecruitingNCT06463262
- KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal CancerRecruitingNCT06411691Phase 1
- Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesRecruitingNCT06398457Early Phase 1
- SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment OptimizationRecruitingNCT06389097
- Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell CarcinomaRecruitingNCT06376669Phase 2
- A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer PatientsRecruitingNCT06315257Phase 1
- PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBCRecruitingNCT06245889Phase 2
- Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+RecruitingNCT06210854Phase 2
- Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal CancerRecruitingNCT06205836Phase 2
- Exercise in Prostate CancerRecruitingNCT06165302Not applicable
- Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer PatientsRecruitingNCT06138067Not applicable
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerRecruitingNCT06059118Phase 2
- Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract CancersRecruitingNCT06001658Phase 2
- Immunobiology Blood and Tissue Collection of Upper Aerodigestive MalignanciesRecruitingNCT05995821
- Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLCRecruitingNCT05950139Phase 1/2
- Pre-operative Hypofractionated Proton TherapyRecruitingNCT05917301Not applicable
- Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric PatientsRecruitingNCT05658731Not applicable
- Renal Retention in High Grade Upper Tract Urothelial CancerRecruitingNCT05656235Phase 2
- Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy SelectionRecruitingNCT05585684
- Cardiometabolic Screening ProgramRecruitingNCT05386719Not applicable
- Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder CancerRecruitingNCT05312671Phase 2
- KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLCRecruitingNCT05254184Phase 1
- Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With GlioblastomaRecruitingNCT05083754Phase 1
- Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N CaRecruitingNCT04988074Phase 2
- Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid CancerRecruitingNCT04892303Phase 1
- Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)RecruitingNCT04704505Phase 2
- Proton Radiation Therapy RegistryRecruitingNCT04376229
- Sequential Testosterone and Enzalutamide Prevents Unfavorable ProgressionRecruitingNCT04363164Phase 2
- DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular CarcinomaRecruitingNCT04248569Phase 1
- Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow FailuresRecruitingNCT04232085Phase 2
- HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical NeoplasiaRecruitingNCT04131413Phase 1
- Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CTRecruitingNCT03861676Early Phase 1
- Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene MutationsRecruitingNCT03786796Phase 2
- Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell CarcinomaRecruitingNCT03521830Phase 2
- Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With SarcomaRecruitingNCT03465592Phase 1/2
- Image-Guided Gynecologic BrachytherapyRecruitingNCT02993900Not applicable
- Reduced Intensity Haploidentical BMT for High Risk Solid TumorsRecruitingNCT01804634Phase 2
- Post-transplant Flotetuzumab for AMLCompletedNCT05506956Phase 1Results posted
- Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate CancerTerminatedNCT05501548Phase 2Results posted
- Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate CancerActive, not recruitingNCT05081193Phase 2Results posted
- Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell LymphomaTerminatedNCT05025423Phase 2Results posted
- Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic CancerCompletedNCT05014776Phase 2Results posted
- Camostat With Bicalutamide for COVID-19TerminatedNCT04652765Phase 1Results posted
- Improving Cancer On-treatment Symptom ManagementCompletedNCT04589247Results posted
- TheraSphere® For Treatment of Metastases in LiverCompletedNCT04517643Not applicableResults posted
- Adaptive Nutrition and Exercise Weight Loss (A-NEW) StudyCompletedNCT04499950Phase 2Results posted
- Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder CancerActive, not recruitingNCT04386746Phase 2Results posted
- Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic CholangiocarcinomaCompletedNCT04301778Phase 2Results posted
- Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric AdenocarcinomaCompletedNCT04209686Phase 2Results posted
- Plerixafor and Cemiplimab in Metastatic Pancreatic CancerCompletedNCT04177810Phase 2Results posted
- Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic SurgeryCompletedNCT04117074Phase 3Results posted
- INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary CancerCompletedNCT04116073Phase 2Results posted
- Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)CompletedNCT04098068Phase 2Results posted
- RAdium-223 and SABR Versus SABR for Oligometastatic Prostate CancersCompletedNCT04037358Phase 2Results posted
- Nivolumab in Biochemically Recurrent dMMR Prostate CancerCompletedNCT04019964Phase 2Results posted
- Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGGTerminatedNCT03973918Phase 2Results posted
- BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 MutationsCompletedNCT03914742Phase 1/2Results posted
- Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate CancerTerminatedNCT03886493Phase 2Results posted
- Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHNCompletedNCT03878979Phase 2Results posted
- Tailored Home-Based Exercise Program for Multiple Chronic ConditionsCompletedNCT03874754Not applicableResults posted
- Automated Method for Breast Cancer DetectionTerminatedNCT03863522Not applicableResults posted
- Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.CompletedNCT03767582Phase 1/2Results posted
- Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal CancerCompletedNCT03711058Phase 1/2Results posted
- Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal CancerCompletedNCT03642067Phase 2Results posted
- CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and TremelimumabCompletedNCT03638141Phase 2Results posted
← Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins overview and focus areas